Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Recalls FlexPen, Penfill Insulin in Europe
Bloomberg
Monday, October 28, 2013 - 9:30am
tags:
Novo Nordisk, recalls, Europe, insulin pen, insulin, diabetes, Penfill, FlexPen
What Might Amarin Be Worth to GlaxoSmithKline or Others?
Motley Fool
Monday, October 28, 2013 - 9:29am
tags:
Amarin, GSK, M&A, Vascepa
Teva Pharm denies report CEO mulling resignation over rift
Yahoo/Reuters
Monday, October 28, 2013 - 9:26am
tags:
Teva, Pharma CEOs, Jeremy Levin
Biogen's new MS drug tops sales expectations, earnings rise
Yahoo/Reuters
Monday, October 28, 2013 - 8:35am
tags:
Biogen Idec, earnings
Merck Profit Beats Analysts’ Estimates on Gardasil Sales
Bloomberg
Monday, October 28, 2013 - 8:32am
tags:
Merck, earnings
Actelion’s Drug Approval Seen Enticing Buyers: Real M&A
Bloomberg
Monday, October 28, 2013 - 8:32am
tags:
M&A, Actelion, Opsumit, Bayer
Now, US FDA gets a call from Indian pharma companies
Business Standard, India
Sunday, October 27, 2013 - 1:01pm
tags:
India, FDA
This Biotech Trifecta Could Revolutionize Cancer
Motley Fool
Sunday, October 27, 2013 - 12:53pm
tags:
Intrexon, Ziopharm, Amgen, Osiris Therapeutics
Celgene arthritis drug appears effective, safe after 1 year -study
Yahoo/Reuters
Sunday, October 27, 2013 - 12:49pm
tags:
Celgene, arthritis, apremilast, psoriatic arthritis
This Week in Biotech
Motley Fool
Sunday, October 27, 2013 - 12:48pm
tags:
Immunomedics, Zogenix, Gilead Sciences, Osiris Therapeutics, Repros Therapeutics
Sequenom Is A Good Short Term Play
Seeking Alpha
Sunday, October 27, 2013 - 12:45pm
tags:
Sequenom
Is It Pharma's Fault That We Don't Have Better Drugs For Malaria, TB And Tropical Diseases?
Forbes
Saturday, October 26, 2013 - 11:29am
tags:
malaria, TB, tuberculosis
Here's Why Medivation Jumped Higher This Week
Motley Fool
Saturday, October 26, 2013 - 11:26am
tags:
Medivation, Xtandi, prostate cancer
Zogenix Wins U.S. Approval for Pure Hydrocodone Pain Pill
Bloomberg
Saturday, October 26, 2013 - 11:25am
tags:
pain management, Zogenix, Zohydro
Will This Pharmaceutical Company Keep Hitting All-Time Highs?
Daily Finance
Saturday, October 26, 2013 - 11:15am
tags:
Shire
Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 World Conference on Lung Cancer
Yahoo/BusinessWire
Saturday, October 26, 2013 - 11:12am
tags:
ganetespib, lung cancer, Synta Pharmaceuticals, adenocarcinoma
Immunogen Inc's CEO Discusses Q1 2014 Results - Earnings Call Transcript
Seeking Alpha
Saturday, October 26, 2013 - 10:57am
tags:
Immunogen, earnings
What Shutdown? Illumina Rises Above The Noise
Seeking Alpha
Saturday, October 26, 2013 - 10:51am
tags:
Illumina
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
investors.com
Saturday, October 26, 2013 - 10:49am
tags:
Biogen Idec, MS, multiple sclerosis
Provenge Drug Maker Dendreon Said to Be Seeking Takeover Offers
Bloomberg
Saturday, October 26, 2013 - 8:08am
tags:
Dendreon, M&A, Provenge

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.